Plain-English translation of NCT04354545 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing , an eye drop medication designed to relieve eye discomfort in people with glaucoma. Many glaucoma patients experience dry, uncomfortable eyes as a side effect of the multiple eye drops they use to control their eye pressure. This study wants to see if the medication can help ease that discomfort.
People with glaucoma often need to use several different eye drop medications every day to manage their condition, and these medications can irritate and dry out the eyes. Researchers want to find out if this treatment can provide relief from that medication-related discomfort.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will use the new eye drop medication in both eyes for 12 weeks as part of your regular glaucoma treatment routine. The study is being conducted at UCLA, and your doctor will monitor how well the treatment works for your eye discomfort during this period.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Collaborators
Bausch & Lomb Incorporated
Enrollment target
~75 participants
Started
April 2021
Primary completion
December 2026
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Benjamin B Bert, MD
University of California, Los Angeles
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.